Papillary thyroid microcarcinoma and active surveillance

Affiliations

¹ Department of Breast and Thyroid Surgery, Union Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, Hubei 430030, China; Division of Endocrinology and Metabolism, Johns Hopkins University School of Medicine, Baltimore, MD, USA.
² Department of Breast and Thyroid Surgery, Union Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, Hubei 430030, China. Electronic address: huangtaowh@163.com.

Comment

Zeming Liu et al. Lancet Diabetes Endocrinol. 2016 Dec.

. 2016 Dec;4(12):974-975.

doi: 10.1016/S2213-8587(16)30269-8.

¹ Department of Breast and Thyroid Surgery, Union Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, Hubei 430030, China; Division of Endocrinology and Metabolism, Johns Hopkins University School of Medicine, Baltimore, MD, USA.
² Department of Breast and Thyroid Surgery, Union Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, Hubei 430030, China. Electronic address: huangtaowh@163.com.

No abstract available

Comment in

Papillary thyroid microcarcinoma and active surveillance - Authors' reply.
Leboulleux S, Tuttle RM, Pacini F, Schlumberger M. Leboulleux S, et al. Lancet Diabetes Endocrinol. 2016 Dec;4(12):976-977. doi: 10.1016/S2213-8587(16)30326-6. Lancet Diabetes Endocrinol. 2016. PMID: 27886753 No abstract available.

Papillary thyroid microcarcinoma: time to shift from surgery to active surveillance?
Leboulleux S, Tuttle RM, Pacini F, Schlumberger M. Leboulleux S, et al. Lancet Diabetes Endocrinol. 2016 Nov;4(11):933-942. doi: 10.1016/S2213-8587(16)30180-2. Epub 2016 Aug 20. Lancet Diabetes Endocrinol. 2016. PMID: 27550849 Review.